Correlation Between Cardio Diagnostics and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Cardio Diagnostics and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Syndax Pharmaceuticals.
Diversification Opportunities for Cardio Diagnostics and Syndax Pharmaceuticals
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cardio and Syndax is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Syndax Pharmaceuticals
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to under-perform the Syndax Pharmaceuticals. In addition to that, Cardio Diagnostics is 2.61 times more volatile than Syndax Pharmaceuticals. It trades about -0.03 of its total potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest 1,794 in Syndax Pharmaceuticals on September 4, 2024 and sell it today you would lose (124.00) from holding Syndax Pharmaceuticals or give up 6.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Cardio Diagnostics |
| Syndax Pharmaceuticals |
Cardio Diagnostics and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Syndax Pharmaceuticals
The main advantage of trading using opposite Cardio Diagnostics and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |